【Taiwan Immigrants' Global News Network】According to the Philippine Daily Inquirer, the administration of booster COVID-19 vaccine shots for the elderly and those with comorbidities will start on November 22, the Department of Health (DOH) said Sunday.
In an advisory, the DOH said that those belonging to A2 (senior citizens) and A3 (persons with comorbidities) categories are now eligible to be given a single COVID-19 booster dose, either a homologous or a heterologous dose starting Monday, Nov. 22.
Seniors, persons with comorbidities to get booster jabs starting Nov. 22. (Photo / Retrieved from the Pixabay)
Among the immunocompromised individuals who are eligible to receive the booster shot are those with immunodeficiency state, people living with HIV, active cancer or malignancy, transplant patients, and patients under immunosuppressive treatments.
Read More: U.S. travel website heaps praise on ‘Taichung Central Park’
A homologous booster shot involves the administration of the same vaccine brand as previously administered, while a heterologous booster shot involves the administration of a different vaccine brand.
Philippine Daily Inquirer says, all those eligible — who were vaccinated with Sinovac, AstraZeneca, Pfizer, Moderna, and Gamaleya Sputnik vaccines as their primary doses — must wait at least six months before getting a booster shot.
Meanwhile, those who were vaccinated with the Janssen COVID-19 vaccine dose as their primary dose series must wait three months before getting the booster shot.
Read More: New Taipei City: #Instaworthy heart-shaped pond becomes a hot tourist attraction
For the heterologous booster dose, DOH recommends the following brands:
Sinovac — AstraZeneca, Pfizer, Moderna
AstraZeneca — Pfizer, Moderna
Pfizer — AstraZeneca, Moderna
Moderna — AstraZeneca, Pfizer
